Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: Pooled results of two large European randomized trials

Journal of Clinical Oncology

Volumn 19, Issue 6, 2001, Pages 1688-1697

  Voogd, A C ^a   Nielsen, M ^a   Peterse, J L ^a   Blichert Toft, M ^a   Bartelink, H ^a   Overgaard, M ^a   Van Tienhoven, G ^a   Andersen, K W ^a   Sylvester, R J ^a   Van Dongen, J A ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER INVASION; CANCER RECURRENCE; CANCER SIZE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RISK ASSESSMENT; RISK FACTOR; SUBCUTANEOUS MASTECTOMY;

EID: 0035868777     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.6.1688     Document Type: Article

References (56)

1. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast
2. Conservative treatment versus mastectomy in breast cancer tumors with macroscopic diameter of 20 millimeters or less: The experience of the Institut Gustave-Roussy
3. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer
4. Results of the National Cancer Institute early breast cancer trial
5. Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer: EORTC 10801 trial
6. Danish randomized trial comparing breast conservation therapy with mastectomy: Six years of life-table analysis
7. Effects of radiotherapy and surgery in early breast cancer: An overview of randomized trials
8. Local control and survival of breast cancer treated by limited surgery followed by irradiation
9. Tumor excision and radiotherapy as primary treatment of breast eancer: Analysis of patients and treatment parameters and local control
10. Mammary recurrences in women younger than forty
11. Long term results with breast-conserving therapy for patients with early stage breast carcinoma in a community hospital setting
12. Predicting the rate and extent of locoregional failure after conservation therapy for early breast cancer
13. The influence of young age on outcome in early stage breast cancer
14. Risk factors in breast-conservation therapy
15. Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer
16. Pathologic predictors of early local recurrence in stage I and II breast cancer treated by primary radiation therapy
17. Identification of patients at high risk of local recurrence after conservative surgery and radiation therapy for stage I or II breast cancer
18. Risk factors for local recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy
19. Local recurrences and distant metastases after conservative breast cancer treatments: Partly independent events
20. Prognostic factors of breast recurrence in the conservative management of early breast cancer: A 25-year follow-up
21. Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy
22. Local relapse and contralateral tumor rates in patients with breast cancer treated with conservative surgery and radiotherapy (Institut Gustave-Roussy 1970-82): IGR Breast Cancer Group
23. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy
24. Tumour bed positivity predicts outcome after breast-conserving surgery
25. Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer
26. Pathological prognostic factors in breast cancer: Experience from a larger study with long-term follow-up
27. Nonparametric estimation from incomplete observations
28. Regression models and life tables
29. Comparison of Halsted mastectomy with quadrantectomy, axillary dissection and radiotherapy in early breast cancer: Long-term results
30. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer
31. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer
32. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer
33. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial
34. Relationship of patient age to pathologic features of the tumor and the risk of local recurrence for patients with stage I or II breast cancer treated with conservative surgery and radiation therapy
35. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast
36. Pathologic findings on re-excision of the primary site in breast cancer patients considered for treatment by primary radiation therapy
37. Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: Pathological findings from NSABP protocol B-06
38. Premenopausal breast cancer patients treated with conservative surgery radiotherapy and adjuvant chemotherapy have a low risk of local failure
39. Prognostic factors for local recurrence in the conservatively treated breast cancer patient: A cautious interpretation of the data
40. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy
41. Lobular carcinoma of the breast can be managed by breast-conserving therapy
42. Conservative surgery for infiltrating lobular carcinoma
43. Infiltrating lobular carcinoma of the breast: Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns
44. Lumpectomy and radiation treatment for invasive lobular carcinoma of the breast
45. Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM): EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group
46. Are prognostic factors for local control of breast cancer treated by primary radiotherapy significant for patients treated by mastectomy
47. The importance of histologic grade in long-term prognosis of breast cancer: A study of 1010 patients, uniformly treated at the Institut Gustave-Roussy
48. Relationship of tumor grade to other pathologic features and to treatment outcome of patients with early stage breast carcinoma treated with breast-conserving therapy
49. Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer
50. Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma
51. Tumor microvessei density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma
52. Age as a prognostic factor in premenopausal breast carcinoma
53. Age as a prognostic factor in breast cancer
54. Relationship of patients age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer
55. Long-term cancer patient survival in the United States
56. Factors influencing the effect of age on the prognosis of breast cancer: Population based study